AI-Driven Drug Discovery Fuels Explosive Demand for Wet-Lab Validation, Creating New Opportunities for Specialized Autoimmune CROs The global population affected by autoimmune diseases continues to ...

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Preclinical CRO Market Size, Share, Trends, and Forecast by Service, End Use, and Region, 2025-2033" has been added to ResearchAndMarkets.com's offering.

Drug development is an unforgiving business. Discovering a novel molecule is difficult enough, but then it can take years of preclinical studies and molecular tweaking to mitigate a drug’s toxicity, ...

At the 2026 AngloNordic conference, industry leaders highlighted a major shift toward AI-driven, non-animal testing methods in drug development, with Merck KGaA aiming to replace most animal protocols ...

Cambridge, MA – Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks ...

Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 ...

Genetically-humanized FcRn mice provide translational pharmacokinetics (PK) and pharmacodynamics (PD) data for antibody-based therapeutics. The image illustrates a therapeutic antibody (blue) adhering ...

SAN FRANCISCO, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Foundery, a biotechnology venture studio focused on translating immunology discoveries into drug candidates, today announced an initial closing of its ...

The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...